News
  Axplora's sustainability strategy substantiated by SBTi as company accelerates action across its manufacturing network,   August 07, 2026
  Neuland Laboratories Q1 net profit stood at Rs.147.4 crore,   August 07, 2026
  9th India Medical Device 2026 commences in New Delhi,   August 07, 2026
  India's medical device industry projected to reach $250 billion by 2047: FICCI-DUA Consulting Report,   August 07, 2026
  NIO study reports smartphone-based AI system, sees high accuracy in detecting eye diseases,   August 07, 2026
  US FDA completes pre-license inspection at CPC Scientific’s Hangzhou cGMP manufacturing facility for Hepcludex API,   August 07, 2026
  PayU partners with Marg ERP to simplify digital Payment collections for pharma distributors and MSMEs,   August 07, 2026
  GenScript Biotech and Tamarind Bio collaborate to connect artificial intelligence molecular design with laboratory validation,   August 07, 2026
  Maharashtra FDA cancels Pune ayurvedic firm's manufacturing licence over GMP & quality violations,   August 07, 2026
  Human cancer models to accelerate research and precision therapies,   August 07, 2026
  Lupin Q1 net profit up 16%,   August 07, 2026
  AiMeD welcomes promotion of 21 drugs inspectors (medical devices) as ADCs,   August 07, 2026
  Adneuris grants exclusive license to Maruishi Pharma to advance cebranopadol in Japan and South Korea,   August 07, 2026
  Thailand to host Third WHO Global Summit on Traditional Medicine in 2027,   August 07, 2026
  Medtronic announces expanded CE Mark indication for Affera Mapping and Ablation System and Sphere-9 catheter to treat ventricular arrhythmias,   August 07, 2026
  Aurobindo Pharma board approves merger of three subsidiaries,   August 07, 2026
  Future of Ayurveda lies in technology, research and innovation: Prataprao Jadhav,   August 07, 2026
  Takeda’s oral orexin receptor 2 agonist, Orzeyful receives US FDA approval to treat the underlying cause of narcolepsy type 1,   August 07, 2026
  Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray,   August 07, 2026
  US FDA accepts Merck’s sBLA for Enflonsia to update its RSV LRTD indication to include children under two years at increased risk for severe RSV for their second season,   August 07, 2026

Results Found: 124068

Go to Total Number of Pages: 6204
 Back
Copyright © 2016 Saffron Media Pvt. Ltd |
counter